Dear Sir or Madam,
We are delighted to present you today the first issue of CARL News!
The new online newsletter format of Resuscitec GmbH will inform you from now on about all top news concerning trade fair appearances, training dates and events around the CARL System.
Over the past twelve years, our company has developed from a start-up to a medium-sized enterprise. Established in 2010 as a spin-off of the Freiburg University Hospital, we have set ourselves the goal of making a fundamental contribution to saving lives more efficiently with our products – thereby shifting the limits of resuscitation.
In the meantime, we have already passed important milestones on the way to this goal. The CARL System got for instance CE-certified in 2020 and in the same year a Post Market Clinical Follow-up Study (PMCF) started at four European centers, which has delivered promising results until today. As a result, we successfully launched CARL in the European market at the beginning of this year – and are now looking forward to continuing the success story of a medical technology vision, which became reality through the contribution of expert scientists and engineers.
Join us on our journey and learn first-hand how CARL will hopefully save more and more lives today and in the future!
Enjoy the reading and best wishes,
Jörg Ronde Christoph Benk
We always use the masculine form in our texts when referring to persons so as not to impair the flow of reading. However, the masculine gender explicitly represents all genders on our website.
Note of use
For copyright reasons, the articles may not be passed on to third parties either in print or digital. They are for personal use only. Building up a database with digitizied articles is not allowed.